Page last updated: 2024-12-11

rhodovibrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

rhodovibrin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5366505
CHEBI ID80149
SCHEMBL ID39362
MeSH IDM0512563

Synonyms (11)

Synonym
rhodovibrin
LMPR01070136
(6e,8e,10e,12e,14e,16e,18e,20e,22e,24e,26e,28e)-31-methoxy-2,6,10,14,19,23,27,31-octamethyldotriaconta-6,8,10,12,14,16,18,20,22,24,26,28-dodecaen-2-ol
SCHEMBL39362
CHEBI:80149
CGEVWQFVGBQXOA-WQMGISBJSA-N
rhodovibrin, all-trans-
lycopene, 3,4-didehydro-1,1',2,2'-tetrahydro-1'-hydroxy-1-methoxy-, all-trans-
.psi.,.psi.-carotene, 3,4-didehydro-1,1',2,2'-tetrahydro-1'-hydroxy-1-methoxy-
(3e)-3,4-didehydro-1,1',2,2'-tetrahydro-psi,psi-carotene #
Q27149266
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
xanthophyllA subclass of carotenoids consisting of the oxygenated carotenes.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
spirilloxanthin and 2,2'-diketo-spirilloxanthin biosynthesis515

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]